Print Icon
 

IBD Update

January 2026

Welcome!

A message from your Chair and Committee Secretary

We hope you all had a break over the festive period.

We have had a busy start to the new year with an IBD focused endoscopy time with a fantastic panel, and the AI webinar an excellent summary of AI tools by Dr Beatriz Gros to support your professional development.


The first IBD360 meeting, a collaboration with the IBD clinical and research group committees in Birmingham was a huge success. A privilege to be able to support the IBD community in delivering good care by the MDT. At Endobridge we had an IBD endoscopy session in Leeds where we discussed the role of endoscopy in the diagnosis, management and cancer surveillance in IBD – we also delivered an additional webinar discussing the cancer risk tool.

 

All podcasts focussed on the updated guidelines are now available (read more below) - please do listen to the guideline committee explore topics in more detail and we would love to hear your feedback.


Several projects are continuing, including development of IBUS and IBD endoscopy - you can read an update below from Dr Christian Selinger.

 

Optimise IBD is making good progress and we are excited at working with the 14 pilot sites to help benchmark data against the IBD standards.

 

We are grateful to have been invited to support Dr Markus Gwiggner (Southampton) as the GI lead on the NHSE online hospital.

 

We also have several initiatives led by committee members to understand variation in therapy prescribing and are grateful for your support to complete all the surveys.

 

We are excited to announce a new collaboration with JAG, led by Dr Alexandra Kent - the BSG/JAG UK Inflammatory Bowel Disease Surveillance Survey to survey all endoscopists in IBD surveillance experience, skills and knowledge to help support recommendations in the BSG IBD Colorectal cancer surveillance guidelines . We are hugely grateful to Prof. Matt Rutter for his support in this work. Please do complete the survey here and help us understand how to develop the future workforce.  

 

Read on!

Shahida Din

Committee Chair

Gareth Parkes

Committee Secretary

     

IBD Question Time is a new initiative from the BSG IBD Committee for insightful discussions, expert opinions and the latest ideas in the world of IBD. These interactive sessions are designed to answer your questions, deepen your knowledge and leave you with ideas for new and innovative ways of delivering your local service.

  

Engage, learn and be part of the conversation. Don’t miss out on this opportunity to expand your expertise! The first IBD Question Time will take place on Tuesday, 3 February 2026 at 17:30 on the theme of Choosing a Medical Therapy in IBD.

 

Got a question you would like discussed? Submit it on your registration form

 

BSG IBD Question Time - Choosing a Medical Therapy in IBD 

     

ECCO Congress 2026  

The Annual Congress of the European Crohn’s and Colitis Organisation (ECCO) takes place in Stockholm, Sweden from February 18 – 21, 2026. 

     

New GIRFT Handbook for Optimising the Care of Patients with IBD 

NHS England’s Getting It Right First Time (GIRFT) programme has developed a new handbook pulling together examples of innovative practice, practical advice and key actions to help optimise the care of NHS patients with inflammatory bowel disease (IBD)

The handbook - aimed at clinicians and operational colleagues working in IBD services - is informed by evidence-based publications and multidisciplinary expertise from across the gastroenterology and general surgery specialties.  It is supported and co-badged by the British Society of Gastroenterology, Crohn’s and Colitis UK, The Dukes’ Club and the Association of Coloproctology of Great Britain and Ireland.  

The new resource offers clear and concise messages, action checklists and links to useful resources for several key areas of focus: the organisation of services, research and training, the multidisciplinary team, access to specialist input, diagnostics, medical management, surgery, data and metrics.  

GIRFT’s clinical lead for gastroenterology, Dr Beverly Oates, said: “Across the country, there are many examples of effective and innovative IBD services. However, during our GIRFT visits we have seen that clinical guidance is not consistently implemented.  


“This handbook aims to address that gap by sharing learning, highlighting proven solutions and describing key actions that can be applied locally. In doing so, it supports the national ambition set out in the 10 Year Health Plan, to take the best of the NHS to the rest of the NHS.”  

     

Mesalazine and idiopathic intracranial hypertension (IIH) 

We would like to thank the MHRA for considering our views on the Drug Safety Update (DSU) regarding mesalazine and idiopathic intracranial hypertension (IIH).  


After a recent review, new warnings about IIH are being added to the product information for all mesalazine medicines.  

These medicines are licensed for the treatment of inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease. 


To put this into context: 

  • Reports of IIH linked to mesalazine are very rare, with only 6 UK Yellow Card reports between 2001 and 2025. 

  • Mesalazine prescribing is very common, with around 1.5 million items issued each year across NHS England (OpenPrescribing.net, Bennett Institute for Applied Data Science, University of Oxford, 2025; accessed 22 May 2025). 

  • The background incidence of IIH in the general population is between 1.8 and 7.8 cases per 100,000 people per year across Scotland, England, and Wales. 

Overall, this means the risk of developing IIH while taking mesalazine is very rare—affecting fewer than 1 in 10,000 people (<0.01%). We want to reassure healthcare professionals that this side effect is extremely unlikely.  People should continue taking their mesalazine as prescribed, because stopping treatment increases the risk of an inflammatory bowel disease flare. 

     

IUS Training in the UK – An Update 

Intestinal bowel Ultrasound (IUS) in IBD care offers many advantages to patients (non-invasive, pain-free, no preparation), the NHS (low cost, direct results allowing instant decision making, freeing up endoscopy and MRI capacity) and the environment (better carbon footprint). Currently provision of IUS in the UK is limited and patchy. The BSG has in collaboration with partner societies developed a plan to increase training capacity and help facilitate a staged nationwide role out of IUS services. Over the coming month we will reach out to clinicians already providing and/or training in IUS and launch the initiative formally with stakeholder engagement.  

     

Did You Know? BSG IBD Endorsed Fellowships 

The BSG is developing a comprehensive database of good quality fellowships for our members. If your Trust offers fellowships, seek BSG 

endorsement for that stamp of approval and better reach. You can read the criteria and apply for endorsement here.


Looking to apply for a good quality fellowship? Browse here.  

     
   

OPTIMISE-IBD

The UK IBD community has developed a number of Key Performance Indictors (KPIs) over recent years with the aim of allowing hospital services to measure, benchmark and improve key aspects of their service provision to IBD patients. The KPIs are: 

1. Time to diagnosis defined as date of referral to date of first clinical diagnosis of IBD made This aligns closely with patient priorities and there is clear evidence of delayed diagnosis leading to worse patient outcomes. 

 2. Time from diagnosis to treatment defined as date of diagnosis to date of treatment This is a UK IBD standard and has been associated with much better outcomes in early treatment as shown by the PROFILE trial. 

 3. Number of steroid courses for existing patients with IBD during the last 12 months prior to clinic review Steroid excess is associated with poor care and that steroid exposure can be reduced by Quality Improvement measures.

 4. Completion of pre-biologic screening checks prior to advanced medication commencement and follow up at 3 and 12 months to assess efficacy and safety 

  

The BSG is now organising and funding a pilot study across the UK for 10-12 sites to test collecting audit information in relation to these KPIs and instigating improvements where required. We have recruited 14 pilot sites and hope to start data collection across the four KPIs in February 2026.

     

Exciting news: Green Gastroenterology Challenge 2026 launches! 


The Centre for Sustainable Healthcare (CSH), in collaboration with the British Society of Gastroenterology, is launching the Green Gastroenterology Challenge 2026, fully funded by Micro-Tech UK. 


Building on the success of the Green Surgery, Green Maternity and Green Nursing Challenges, this national programme supports gastroenterology teams to deliver practical, sustainable quality improvement with real impact on patient care and carbon. 


We’re running a webinar on Monday 9 February 2026 18:00-19:00 to introduce the Challenge and explain how gastroenterology teams can apply to take part. Whether you are new to sustainable healthcare or already leading change in your service, this event will show how sustainable practice can align with high-quality, equitable patient care. 

     

BSG Podcast: From Top to Bottom

Our new podcast, From Top to Bottom, gives you all the latest insights shaping modern gastroenterology practice from inspirational interviews to guideline summaries from leading experts.


Whether you're a gastroenterologist, trainee, or other healthcare professional seeking practical, evidence-based updates this podcast keeps you current from top to bottom.

We have now released a seven-part series, covering the main chapters of the IBD Guideline (2025), featuring prominent members of the Guideline development group. 


Do you have an idea for a podcast you’d like to share?   Share your ideas here. 

     

Surveys - Have Your Say

Support for IBD Nurses 

The BSG IBD Section has started a piece of work looking at how we can better support our IBD nurses. CCUK is currently running a survey to determine 

optimal caseloads for IBD nursing teams. 

Prescribing practices of IBD Consultants in the UK

Dr Ajay Verma and Dr Shahida Din from the IBD committee have created surveys to evaluate the prescribing practices of IBD Consultants in the UK in the post UK IBD guideline landscape. They would appreciate if Consultant Gastroenterologists who manage patients with IBD complete the survey.

 

The surveys are short and shouldn't take long to complete. Surveys are easier to complete on desktop / laptop.

   
   
Facebook
Twitter
LinkedIn
Email

Copyright © 2026 The British Society of Gastroenterology, All rights reserved. You are receiving this email because you are currently or have been a member of The British Society of Gastroenterology.